Lioton (Heparin Sodium)

Heparin sodium binds to antithrombin III, accelerating its inhibition of thrombin (factor IIa) and factor Xa. This blocks the conversion of fibrinogen to fibrin, reducing clot formation. When applied topically, the effect is confined to the site of application, providing localized anticoagulation without significant systemic absorption.

The specific amount of Lioton to apply is determined by the prescribing healthcare professional based on the indication, size of the area, and patient factors. The product is typically applied as a thin layer to the affected skin once or twice daily, but exact dosing must follow the prescriber’s instructions.

Safety data for topical heparin sodium during pregnancy and lactation are limited. Because systemic exposure is minimal, it is generally considered low risk, but the product should only be used if the potential benefit outweighs any possible risk. Consultation with an obstetrician or pediatrician is advised before use.

To place an order, submit an enquiry on the Lioton product page at gnhindia.com, providing the required quantity and your institutional credentials. GNH India works with hospitals, pharmacies and procurement teams worldwide, then responds with pricing, availability, shipping details (including any cold‑chain needs) and the necessary import documentation.

Compared with systemic anticoagulants such as oral warfarin or injectable low‑molecular‑weight heparin, Lioton offers localized action with minimal systemic exposure, reducing the risk of systemic bleeding. It is also distinct from topical NSAIDs, which address inflammation but do not provide anticoagulant effects. Choice depends on the clinical situation and the need for localized versus systemic therapy.

Lioton should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed when not in use and avoid exposure to extreme temperatures, which could affect the stability of the heparin sodium.

Lioton is applied topically to clean, dry skin over the affected area. The prescribed amount is spread as a thin, even layer and gently massaged in until absorbed. The frequency of application—typically once or twice daily—depends on the clinician’s recommendation and the severity of the condition.

Although systemic absorption is low, serious adverse reactions can occur, including severe hypersensitivity, anaphylaxis, or heparin‑induced thrombocytopenia (HIT) that may lead to unexpected bleeding. Patients should be monitored for signs of extensive bruising, skin necrosis, or systemic bleeding, and the product should be discontinued immediately if such events arise.

Lioton should be avoided in individuals with known hypersensitivity to heparin or any excipients in the formulation. It is also contraindicated on open wounds, infected skin lesions, or in patients with active bleeding disorders unless specifically directed by a physician. Pregnant or breastfeeding women should only use it after professional medical evaluation.